AVDL
Price
$22.93
Change
-$0.00 (-0.00%)
Updated
Nov 25, 04:56 PM (EDT)
Capitalization
2.24B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVDL

Header iconAVDL Comparison
Open Charts AVDLBanner chart's image
Avadel Pharmaceuticals
Price$22.93
Change-$0.00 (-0.00%)
Volume$5.86K
Capitalization2.24B
AVDL Comparison Chart in %
AVDL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), BioCryst Pharmaceuticals (NASDAQ:BCRX), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.11B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 0%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 17%. RGTLF experienced the highest price growth at 795%, while APUS experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was 16%. For the same stocks of the Industry, the average monthly volume growth was 48% and the average quarterly volume growth was 65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 62
Price Growth Rating: 60
SMR Rating: 79
Profit Risk Rating: 90
Seasonality Score: -1 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Nov 25, 2025
Stock price -- (AVDL: $22.91)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVDL’s FA Score shows that 1 FA rating(s) are green while.

  • AVDL’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVDL’s TA Score shows that 4 TA indicator(s) are bullish.

  • AVDL’s TA Score: 4 bullish, 4 bearish.

Price Growth

AVDL (@Pharmaceuticals: Generic) experienced а -0.48% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.34%. For the same industry, the average monthly price growth was -5.94%, and the average quarterly price growth was +16.91%.

Reported Earning Dates

AVDL is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.34% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVDL
Capitalization2.25B
EBITDA7.87M
Gain YTD117.983
P/E RatioN/A
Revenue221M
Total Cash81.5M
Total Debt2.73M
FUNDAMENTALS RATINGS
AVDL: Fundamental Ratings
AVDL
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
87
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
34
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVDL
RSI
ODDS (%)
Bearish Trend 6 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
AVDL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSRYX42.580.48
+1.14%
Columbia Select Large Cap Value Inst3
MRSRX25.140.02
+0.08%
MFS Research International R2
AHSAX22.30N/A
N/A
Alger Health Sciences A
WOOPX17.26N/A
N/A
JPMorgan SMID Cap Equity I
ABGNX20.94N/A
N/A
American Century Balanced R5

AVDL and Stocks

Correlation & Price change

A.I.dvisor tells us that AVDL and RMTI have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVDL and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVDL
1D Price
Change %
AVDL100%
-0.52%
RMTI - AVDL
31%
Poorly correlated
+2.15%
VTRS - AVDL
30%
Poorly correlated
+2.32%
ELAN - AVDL
30%
Poorly correlated
+3.78%
COLL - AVDL
27%
Poorly correlated
+1.02%
HROW - AVDL
27%
Poorly correlated
+0.23%
More